XML 21 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Total
Total
Cumulative Effect, Period of Adoption, Adjustment
Total
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury Stock
Treasury Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Noncontrolling Interest
Noncontrolling Interest
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2021             25,300,793                    
Beginning balance at Dec. 31, 2021 $ 704,906     $ 704,817     $ 120,615   $ 583,134     $ 16,093   $ (15,025)   $ 89  
Increase (Decrease) in Stockholders' Equity                                  
Net income 103,817     103,817         103,817                
Other comprehensive (loss) income, net of tax (205,016)     (205,016)               (205,016)          
Cash dividends declared (40,851)     (40,851)         (40,851)                
Treasury shares purchased under deferred directors' plan (in shares)             (7,641)                    
Treasury shares purchased under deferred directors' plan 0     0     $ 579             (579)      
Treasury shares sold and distributed under deferred directors' plan (in shares)             8,555                    
Treasury shares sold and distributed under deferred directors’ plan 0     0     $ (221)             221      
Stock activity under equity incentive plans (in shares)             47,518                    
Stock activity under equity incentive plans (1,780)     (1,780)     $ (1,780)                    
Stock based compensation expense 7,811     7,811     $ 7,811                    
Ending balance (in shares) at Dec. 31, 2022             25,349,225                    
Ending balance at Dec. 31, 2022 568,887     568,798     $ 127,004   646,100     (188,923)   (15,383)   89  
Increase (Decrease) in Stockholders' Equity                                  
Net income 93,767     93,767         93,767                
Other comprehensive (loss) income, net of tax 33,728     33,728               33,728          
Cash dividends declared (47,107)     (47,107)         (47,107)                
Treasury shares purchased under deferred directors' plan (in shares)             (10,073)                    
Treasury shares purchased under deferred directors' plan 0     0     $ 575             (575)      
Treasury shares sold and distributed under deferred directors' plan (in shares)             12,855                    
Treasury shares sold and distributed under deferred directors’ plan 0     0     $ (405)             405      
Stock activity under equity incentive plans (in shares)             78,559                    
Stock activity under equity incentive plans (3,135)     (3,135)     $ (3,135)                    
Stock based compensation expense $ 3,653     3,653     $ 3,653                    
Ending balance (in shares) at Dec. 31, 2023 25,430,566           25,430,566 25,430,566                  
Ending balance at Dec. 31, 2023 $ 649,793 $ (532) $ 649,261 649,704 $ (532) $ 649,172 $ 127,692 $ 127,692 692,760 $ (532) $ 692,228 (155,195) $ (155,195) (15,553) $ (15,553) 89 $ 89
Increase (Decrease) in Stockholders' Equity                                  
Net income 93,478     93,478         93,478                
Other comprehensive (loss) income, net of tax (11,305)     (11,305)               (11,305)          
Cash dividends declared (49,294)     (49,294)         (49,294)                
Treasury shares purchased under deferred directors' plan (in shares)             (9,394)                    
Treasury shares purchased under deferred directors' plan 0     0     $ 592             (592)      
Treasury shares sold and distributed under deferred directors' plan (in shares)             13,275                    
Treasury shares sold and distributed under deferred directors’ plan 0     0     $ (391)             391      
Stock activity under equity incentive plans (in shares)             75,145                    
Stock activity under equity incentive plans (2,815)     (2,815)     $ (2,815)                    
Stock based compensation expense $ 4,586     4,586     $ 4,586                    
Ending balance (in shares) at Dec. 31, 2024 25,509,592           25,509,592                    
Ending balance at Dec. 31, 2024 $ 683,911     $ 683,822     $ 129,664   $ 736,412     $ (166,500)   $ (15,754)   $ 89